Streptococcus pneumoniae is an important cause of lifethreatening diseases such as pneumonia, bacteremia, and meningitis, as well as less severe but highly prevalent infections such as otitis media and sinusitis. Such infections are generally preceded by colonization of the nasopharyngeal mucosa (23) , and in one study, it was estimated that approximately 15% of young children colonized by pneumococci went on to develop disease (8) . Little, however, is understood of the mechanism whereby the colonizing pneumococci penetrate the physical defenses of the host and invade tissues (3) .
We have previously shown that both pneumolysin and autolysin contribute to the virulence of S. pneumoniae. Pneumococci carrying defined mutations in either of these genes were less virulent than their otherwise isogenic parents (1, 2) . However, the fact that these mutants were still capable of killing mice, albeit at high doses, suggested that other pneumococcal products were also important. It has been known for many years that pneumococci, as well as other members of the genus Streptococcus, produce hyaluronidase (11, 21) . This enzyme hydrolyzes hyaluronic acid, which is an important component of connective tissues, and thus hyaluronidase might contribute directly to invasion. Boulnois et al. (4) have reported that the vast majority of clinical isolates of S. pneumoniae produce hyaluronidase. They also reported the isolation of a hyaluronidase-producing lambda gtl 1 clone from a pneumococcal gene library (4) . Further characterization of this gene or of the hyaluronidase itself has not yet been reported.
In the present study we describe the cloning and sequencing of the gene encoding the pneumococcal hyaluronidase as well as a procedure for purification of the enzyme from recombinant Escherichia coli. 
MATERIALS AND METHODS
Bacterial strains and cloning vectors. The S. pneumoniae strains used in this study were clinical isolates belonging to serotypes 20 and 23. These organisms were routinely grown in Todd-Hewitt broth containing 0.5% yeast extract or on bloodagar plates. The E. coli K-12 strains, DH1 (9) and DH5ot (Bethesda Research Laboratories, Gaithersburg, Md.), were grown in Luria-Bertani (LB) medium (18) with or without 1.5% Bacto-Agar (Difco Laboratories, Detroit, Mich.). Where appropriate, ampicillin or kanamycin was added to growth media at a concentration of 50 ,ug/ml. The 10.2-kb, low-copynumber, inducible cosmid vector pOU61cos, which encodes ampicillin resistance, has been described by Knott et al. (15) . The 2.4-kb plasmid pK184, which encodes kanamycin resistance, has also been described previously (13) , and the 3.0-kb phagemid pBluescript SK, which encodes ampicillin resistance, was obtained from Stratagene, La Jolla, Calif.
S. pneumoniae chromosomal DNA extraction. S. pnelumoniae chromosomal DNA for use in cloning and Southern blot hybridization experiments was extracted and purified as described previously (24) .
Construction of cosmid gene bank of S. pneumoniae. Highmolecular-weight chromosomal DNA (27) . DNA was fixed onto the filters by treatment with 0.4 M NaOH, prehybridized, and then hybridized to probe DNA and washed at high stringency, as described by Maniatis et al. (18) . Probe DNA was labelled according to the method of Feinberg and Vogelstein (7) in the presence of digoxigenin-1 1-dUTP (Boehringer, Mannheim, Germany). Washed filters were developed with anti-digoxigenin-alkaline phosphatase conjugate (Boehringer) and a 4-nitroblue tetrazolium-X-phosphate substrate system, according to the manufacturer's instructions.
Plasmid DNA preparation. Plasmid DNA was prepared by the alkaline lysis miniprep method of Morelle (22) .
Transformation. Transformation of E. coli with plasmid DNA was carried out with CaCl2-treated cells as described by Brown et al. (6) .
PAGE and Western blot analysis. SDS-PAGE was carried out as described by Laemmli (16) , and where appropriate, gels were stained with Coomassie brilliant blue R250. For Western blot analysis, proteins were electrophoretically transferred from SDS-PAGE gels onto nitrocellulose filters, as described by Towbin et al. (28) . Filters were probed with hyaluronidase antiserum or control serum (used at a dilution of 1:1,000) followed by goat anti-mouse immunoglobulin G (IgG) conjugated to horseradish peroxidase (Bio-Rad Laboratories, Richmond, Calif.). Enzyme-labelled bands were visualized with a 4-chloro-1-naphthol-H202 substrate system. DNA sequencing. Nested deletions of cloned DNA in pBluescript SK were constructed by the method of Henikoff (10) with an Erase-a-Base kit (Promega). These were transformed into E. coli DH5ot, and plasmid DNA was extracted from the resultant clones, as described above. Double-stranded-DNA sequencing was then carried out with dye-labelled primers on an Applied Biosystems model 373A automated DNA sequencer.
Amino acid sequencing. Sequencing was carried out on purified hyaluronidase, which had been electroblotted onto an Immobilon-P membrane, as described by Matsudaira (20) . Protein bands were excised from the membrane, placed in a modified cartridge, as described by Williams et al. (29) , and analyzed on an ABI 470A protein sequenator equipped with an on-line phenylthiohydantoin-amino acid analyzer.
Nucleotide sequence accession number. The nucleotide sequence of the insert of pJCP802 has been deposited with GenBank (accession number L20670).
RESULTS
Isolation of hyaluronidase-producing clones from a cosmid gene bank and subcloning. A gene bank of SauM3A1-generated S. pneumoniae type 23 DNA fragments was constructed in E. coli DH1 with the low-copy-number cosmid vector pOU61cos, as described in Materials and Methods. Cell lysates were prepared from approximately 800 of the recombinant clones, and these were screened by immunoblotting using a mouse antiserum raised against a crude pneumococcal hyaluronidase preparation. One immunoreactive clone was detected, and lysates from this clone produced high levels of hyaluronidase activity after induction at 42°C for 2 h (approximately 39,000 NFU/ml). This clone contained a recombinant cosmid (designated pJCP800) with a 30-to 35-kb pneumococcal DNA insert.
In order to subclone the hyaluronidase coding region, pJCP800 DNA was digested with PstI or HindIll and fragments were ligated with appropriately digested pK184 and transformed into E. coli DH5oL. Lysates of kanamycin-resistant transformants were then assayed for hyaluronidase activity. A recombinant plasmid, designated pJCP801, with a 5.6-kb PstI DNA insert was isolated from a hyaluronidase-positive clone. A restriction map of pJCP801 is shown in Fig. 1 . The 5.6-kb insert of pJCP801 included approximately 1.5 kb derived from pOU61cos. To further localize the hyaluronidase gene within the insert of pJCP801, a deletion derivative lacking approximately 600 bp from the lefthand end of the pJCP801 insert (i.e., the end opposite that containing the cosmid-derived sequences) was constructed by exonuclease III digestion, and E. coli DH5ot harboring this plasmid failed to produce hyaluronidase activity. This suggested that the coding region was located in the proximal portion of pJCP801, and so a 3.8-kb PstI-ClaI fragment was subcloned into pBluescript SK (Fig. 1) . Subcloning was carried out in two steps owing to the presence of an additional Clal site approximately 1.4 kb from the lefthand end of the insert. This involved cloning the 1.4-kb PstI-ClaI fragment into PstI-ClaI-digested pBluescript SK, and then the 2.4-kb Clal fragment was inserted into this construct after linearization with C/al. The correct orientation of the Clal fragment with respect to the proximal region was confirmed by restriction analysis using EcoRI and Xbal. E. coli DH5cx carrying this plasmid, designated pJCP802, produced 1,560 NFU of hyaluronidase per ml of cell lysate.
To confirm that the pneumococcal DNA insert in pJCP802 had not undergone a major rearrangement during cloning and subcloning, plasmid DNA, as well as S. pneumoniac serotype 23 DNA, was digested with Clal, EcoRI, or Clal plus PstI and subjected to Southern hybridization analysis (Fig. 2) . On the basis of the restriction map of pJCP802 (Fig. 1) , reactive fragment sizes of 2.4 kb, 2.5 kb, and 2.4 kb plus 1.4 kb would also be expected for the three respective digests of S. pneuimoniae DNA. Both S. pneumoniae serotype 23 and pJCP802 digests contained probe-reactive restriction fragments of the expected size, indicating that the insert of pJCP802 represented contiguous pneumococcal DNA sequences. These data also suggested that there is only one copy of the hyaluronidase gene in the S. pneumoniae chromosome.
DNA sequence analysis. Nested-deletion derivatives of pJCP802 were constructed, and both strands of the insert were sequenced (see Fig. 1 for the sequencing scheme). The DNA sequence of appropriate nested-deletion derivatives of a 2.5-kb EcoRI fragment from pJCP801, which was subcloned into pBluescript SK, was also determined to confirm that there was not a second internal ClaI site within the gene which might have resulted in a small deletion during construction of pJCP802. The complete nucleotide sequence is shown in Fig. 3 
This sequence is identical to residues 164 to 179 of the predicted amino acid sequence for the 107-kDa polypeptide, except that the deduced sequence is L rather than M at position 164. This implies that initiation is occurring at the TFG codon at this position and that therefore the amino acid specified is M rather than L. Initiation at this point would be expected, from the DNA sequence data, to result in a 786-amino-acid polypeptide with an Mr of 89,413, which agrees closely with that of the purified hyaluronidase, as estimated by SDS-PAGE.
The hyaluronidase produced by E. coli DH5oc(pJCP802) and S. pneumoniae was also analyzed, with a mouse antiserum raised against the purified recombinant hyaluronidase. The antiserum (but not preimmune mouse serum) completely neutralized hyaluronidase activity in extracts of E. coli DH5ot(pJCP802) and a partially purified hyaluronidase extract from S. pneumoniae (results not shown). When these extracts were subjected to Western blot analysis (Fig. 6) , the antiserum labelled at least 20 protein species in extracts of E. coli DH5x(pJCP802), only three of which were detected in extracts of DH5ot(pBluescript SK). The largest antibody-reactive pJCP802-encoded polypeptide was approximately 107 kDa, which agrees closely with the size of the predicted translation product of the complete open reading frame. A polypeptide of similar size was labelled in the partially purified hyaluronidase extract from S. pneumoniae. These results suggest that in E. coli at least two translation initiation sites are recognized and that the polypeptides transcribed from these sites are susceptible to extensive proteolytic cleavage. In S. pneumoniae, however, only a 107-kDa hyaluronidase antibody-reactive polypeptide was detected, suggesting that there is only one translation initiation site recognized. Moreover, there was no evidence for proteolytic processing of hyaluronidase in S.
pneumoniae.
To further examine the possibility that hyaluronidase translation products are susceptible to proteolytic cleavage in E. coli, purification of the enzyme from extracts of E. coli DH5ot(pJCP802) was carried out, as described above, except that all column buffers were supplemented with protease inhibitors ( (Fig. 7) .
DISCUSSION
Given its substrate specificity, it is possible that hyaluronidase plays a role in pneumococcal pathogenesis by allowing greater microbial access to host tissue for colonization. It may also play a role in the migration of the organism between tissues, for example, translocation from the lung to the vascular system. Another way in which hyaluronidase might contribute to virulence or survival of pneumococci in the host is by scavenging potential carbon sources, such as glucose and glucuronic acid. Further analysis of the contribution (if any) of hyaluronidase to the pathogenesis of pneumococcal disease has been frustrated by the lack of basic information on the enzyme (it has not been purified previously) or the gene which encodes it. In the present study we have cloned and sequenced the S. pneumoniae gene encoding hyaluronidase and purified an active hyaluronidase from recombinant E. coli. N-terminal amino acid sequence analysis indicated that the 89-kDa hyaluronidase, which was purified to apparent homogeneity as judged by SDS-PAGE, was likely to have been translated from an internal (in-frame) ]TG codon within the major open reading frame. Western blot analysis using an antiserum raised against the 89-kDa enzyme specifically labelled a large number of polypeptides in extracts of E. coli DH5ot(pJCP802), while there was negligible labelling of similar extracts derived from the parental host/vector. The largest immunoreactive species detected in the hyaluronidase-producing clone was ap- proximately 107 kDa, the same size as that expected from the deduced amino acid sequence of the major open reading frame. Moreover, a 107-kDa protein was labelled in a partially purified hyaluronidase preparation from S. pneumoniae, and enzymatic activity in this extract was neutralized by the antiserum. The large number of smaller hyaluronidase antibodyreactive species in DH5ot(pJCP802) extracts suggests that extensive proteolytic cleavage of hyaluronidase occurs in E. coli. Indeed, when protease inhibitors (PMSF and EDTA) were included in buffers used for purification of hyaluronidase from DH5ox(pJCP802) lysates, the final preparation consisted of approximately equal amounts of 89-, 91-, and 94-kDa proteins, all of which reacted strongly with the hyaluronidase antiserum in Western blots. However, the fact that the Nterminal amino acid sequence of the 89-kDa form commenced with a TTG-encoded Met residue indicates that this species has not been subjected to N-terminal processing. There were no alternative potential initiation codons upstream which might account for the 91-and 94-kDa species, and so presumably these are intermediate degradation products of the 107-kDa primary translation product. There was insufficient resolution on SDS-PAGE to permit separate determination of the N-terminal amino acid sequence of the 91-and 94-kDa forms, and it is not known whether these particular forms are enzymatically active. Collectively, the results described above imply that, in E. coli, the pneumococcal hyaluronidase is translated from at least two initiation codons and that these translation products are susceptible to proteolysis. It is also likely that two separate promoter sites are recognized, as E. coli carrying a deletion derivative of pJCP802 lacking nucleotides 1 to 329 retained full hyaluronidase activity. The deleted region includes the putative promoter site for the 107-kDa enzyme as well as the first 240 nucleotides of the major open reading frame. Thus, sequences downstream from nucleotide 330 are capable of directing expression of an active portion of the hyaluronidase coding sequence. Deletion derivatives lacking nucleotides 1 to 654 were hyaluronidase negative (results not presented). We are currently using promoterless chloramphenicol acetyltransferase expression vectors to locate promoter sequences in the region immediately upstream from the initiation codon (nucleotide 579) for the 89-kDa form of the enzyme. In S. pneumoniae, however, only one initiation site appears to be recognized and there was no evidence of proteolytic cleavage.
Regardless of the translation initiation site recognized in E. coli, the pneumococcal hyaluronidase lacks a signal peptide, and in E. coli, the enzyme remains cell associated. In S. pneumoniae cultures, hyaluronidase is found in both the culture supernatant and the cell-associated fraction. However, the appearance of hyaluronidase activity in the culture supernatant precisely parallels the appearance of pneumolysin (results not presented). Pneumolysin is a cytoplasmic protein which is released only when pneumococci undergo autolysis (1, 14) . Thus, it appears that pneumococcal hyaluronidase may also be a cytoplasmic protein, a fact consistent with the absence of an N-terminal signal peptide.
The hyaluronidase gene from Streptococcus pyogenes bacteriophage H448A has also been cloned and sequenced (12 encoded protein is much smaller (39.5 kDa) than the pneumococcal enzyme, and there is negligible homology at the amino acid level between the two sequences. An apparently unpublished sequence for the hyaluronidase gene of Clostridilum perfringens has also been deposited in GenBank (accession number M81878). The size of this enzyme, calculated from the deduced amino acid sequence (117.6 kDa), is closer to that of the pneumococcal hyaluronidase, but again there is no significant homology between the two enzymes at the amino acid level. Thus, sequence comparisons have not identified any structurally conserved regions, which may have provided an indication of residues important for catalytic activity. Clearly, for the pneumococcal hyaluronidase, the N-terminal region is not essential, as the 89-kDa form, which lacks the first 163 residues found in the 107-kDa form, retains high specific activity (800 times that of a commercial bovine testicular hyaluronidase preparation). The 107-kDa form of hyaluronidase is also presumed to be enzymatically active, as no other species were detected in pneumococcal lysates. In this respect, hyaluronidase is remarkably similar to the pneumococcal neuraminidase; multiple forms of this enzyme also appear to exist, the largest being 107 kDa. However, proteolytic cleavage generates an 86-kDa fragment which retains full neuraminidase activity (17) . Interestingly, it has been reported recently that the neuraminidase of group B streptococci is actually a hyaluronidase (26) , raising the possibility that, in S. pneuimoniae, the two enzymes might actually be the same protein. However, the purified pneumococcal hyaluronidase had no detectable neuraminidase activity when 2'-(4-methylumbelliferyl)-ox-D-N-acetylneuraminic acid was used as the substrate, and purified pneumococcal neuraminidase did not have any hyaluronidase activity. Furthermore, there was no immunological cross-reaction between the two proteins (results not presented).
Western blot analysis suggested that the total amount (by weight) of enzyme produced in S. pnieumoniae may be very low, as only weak signals were obtained when crude pneumococcal culture lysates were probed (results not shown). Indeed, it was necessary to partially purify and concentrate these lysates in order to obtain a signal strong enough for photographic reproduction. The apparent differences in intensity of labelling in Western blots were nevertheless consistent with the total amounts of enzyme activity present in S. pnelmroniae and recombinant E. coli lysates.
Some uncertainty remains concerning the precise regulatory regions involved in expression of hyaluronidase both in E. coli and in S. pneumoniae. Nevertheless, access to the cloned gene and determination of the complete nucleotide sequence will allow the study of the role of hyaluronidase in vivo via the construction of defined hyaluronidase-negative pneumococci for use in animal models of infection.
